Vertex Pharmaceuticals (VRTX)

Deferred Revenue

$0.00

Quarterly · Period ending: · USD

VRTX logo

VRTX Deferred Revenue

Latest reported$0.00
VRTX Quarterly Deferred Revenue ($0.00 → $0.00)
High-resolution chart · PNG

VRTX deferred revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals Deferred Revenue — Quarterly (USD)
Period endingDeferred Revenue (USD)
0
0
171,800,000
0
0
0
206,800,000
0
0
0
170,300,000
0
0
0
159,600,000
0
0
0
171,700,000
0
0
0
191,500,000
0
0
0
62,332,000
0
0
0
24,870,000
0
0
0
237,570,000
203,275,000
154,963,000
110,831,000
79,421,000
9,247,000
11,468,000
14,705,000
16,296,000
14,000,000
14,930,000
15,918,000
17,468,000
21,210,000
27,174,000
28,836,000
21,510,000
31,007,000
32,900,000
35,533,000
27,566,000
27,303,000
27,296,000
30,491,000
45,037,000
55,695,000
65,018,000
74,193,000
74,619,000
98,977,000
78,273,000
69,575,000
74,956,000
74,609,000
37,787,000
37,679,000
37,678,000
36,404,000
35,575,000
23,683,000
25,528,000
24,017,000
24,436,000
34,100,000
33,889,000
37,192,000
42,931,000
23,656,000
31,449,000
32,511,000
44,483,000
50,889,000
47,741,000
41,018,000
39,742,000
9,351,000
7,746,000
8,774,000
9,920,000
14,108,000
11,888,000
19,032,000
21,775,000
27,879,000
39,498,000
53,747,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.